About kyle.mcneir@artifactorie.com

This author has not yet filled in any details.
So far kyle.mcneir@artifactorie.com has created 21 blog entries.

INDICAID® COVID-19 Rapid Antigen Test Detects Omicron Variant B.1.1.529 & Sub-Variant BA.2 (B.1.1.529.2)

Phase Scientific continuously monitors emerging variants of the virus that causes COVID-19 and how their mutations may impact the performance of the INDICAID® COVID -19 Rapid Antigen Test.

An independent evaluation by the National Institutes of Health (NIH) RADx Variant Task Force has determined that the INDICAID test detects the […]

INDICAID® COVID-19 Rapid Antigen Test Detects Omicron Variant B.1.1.529 & Sub-Variant BA.2 (B.1.1.529.2)2022-05-14T02:51:56+05:00

PHASE Scientific Americas Launches Online Shop for At-Home COVID-19 Tests

INDICAID® OTC COVID-19 Rapid Antigen Tests Now Available for Direct Consumer Purchase

GARDEN GROVE, CA, April 25, 2022 — PHASE Scientific Americas (PHASE Scientific), a high-growth biotech company founded by bioengineers from UCLA, announces that its EUA approved INDICAID® COVID-19 Rapid Antigen At-Home Test (INDICAID® OTC) is now available for […]

PHASE Scientific Americas Launches Online Shop for At-Home COVID-19 Tests2022-04-25T23:56:39+05:00

INDICAID’S Omicron Variant Update

INDICAID’s Omicron BA.2 Variant Update

April 04, 2022

Phase Scientific continuously monitors emerging variants of the virus that causes COVID-19 and how their mutations may impact the performance of the INDICAID® COVID-19 Rapid Antigen test. A sub-variant of Omicron designated BA.2 (B.1.1529.2) was detected in the U.S. in January 2022, and the Centers […]

INDICAID’S Omicron Variant Update2022-04-13T20:57:40+05:00

Facing the “Stealth Omicron” Sub-variant’s Dominance Head-On

No New Surges Means Good Preventive Care

Despite its pervasiveness and spikes in Asia and Europe, the Covid-19 Omicron BA.2—dubbed the Stealth Omicron by the World Health Organization (WHO)—has appeared to have lost its choke-hold on the U.S. It’s stealthy no more, Carl Zimmer remarks in his New York Times piece.

Omicron BA.2 […]

Facing the “Stealth Omicron” Sub-variant’s Dominance Head-On2022-03-29T23:27:16+05:00

A Premium At-Home COVID-19 Rapid Antigen Testing Product Hits U.S. Retail Stores

PHASE Scientific’s INDICAID® Covid-19 Rapid Antigen Test Obtains FDA Emergency Use Authorization (EUA) for Over-the-Counter (OTC), Asymptomatic, Non-Prescription Use

March 16, 2022 :  The biotech conglomerate, PHASE Scientific USA, announced the FDA’s EUA green-light to launch INDICAID® Covid-19 Rapid Antigen Over-the-Counter (OTC)
tests nationwide. With INDICAID® OTC Delivered to leading retailers across the […]

A Premium At-Home COVID-19 Rapid Antigen Testing Product Hits U.S. Retail Stores2022-03-30T03:14:25+05:00

INDICAID® OTC COVID-19 Rapid Antigen At-Home Test Receives FDA EUA

PHASE Scientific’s COVID-19 Rapid Antigen At-Home Test Now Available Across the U.S.—Enabling the American Public to Perform the Test On-Demand

GARDEN GROVE, Calif., March 22, 2022 /PRNewswire/ — PHASE Scientific International, LTD (PHASE Scientific), a high-growth biotech company founded by bioengineers from UCLA, announces that its INDICAID® COVID-19 Rapid Antigen […]

INDICAID® OTC COVID-19 Rapid Antigen At-Home Test Receives FDA EUA2022-03-30T03:13:15+05:00

AMA Updated Coding Guidelines

Best Coding Practices for Coverage of Covid-19 Testing, Monitoring, and Telehealth

Late last year, the American Medical Association (AMA) released an updated version of its document, ‘Special coding advice during COVID-19 public health emergency.’

This updated version, labeled v3.2, provides a broader list of coding scenarios, now 26 from the […]

AMA Updated Coding Guidelines2022-03-04T19:57:55+05:00

Hong Kong’s Hospitals Reach a Breaking Point as Infections Skyrocket

Will Antiviral Drugs Make Significant Impact?

As PHASE Scientific USA continues to monitor the pandemic on a global scale, the spotlight has fallen on Hong Kong, where the count of daily COVID-19 cases has reached upwards of 4,000 for the very first time.

The steep surge of cases has inundated […]

Hong Kong’s Hospitals Reach a Breaking Point as Infections Skyrocket2022-02-22T20:08:56+05:00

Performance of the INDICAID® COVID-19 Rapid Antigen Test Against Omicron Variant (B.1.1.529)

The B.1.1.529 variant, termed the Omicron variant, is a highly transmissible SARS-CoV-2 variant of concern. It is important that current SARS-CoV-2 diagnostic tests remain capable of detecting the B.1.1.529 variant. This white paper describes our evaluation of the INDICAID® COVID-19 Rapid Antigen Test when used to detect specimens containing the […]

Performance of the INDICAID® COVID-19 Rapid Antigen Test Against Omicron Variant (B.1.1.529)2022-02-18T03:07:09+05:00

FAQS About Families First Coronavirus Response Act

And Coronavirus Aid, Relief, And Economic Security Act Implementation Part 52

February 4, 2022 : Set out below are Frequently Asked Questions (FAQs) regarding implementation of the Families First Coronavirus Response Act (FFCRA) and the Coronavirus Aid, Relief, and Economic Security Act (CARES Act). These FAQs have been prepared jointly by the […]

FAQS About Families First Coronavirus Response Act2022-02-17T23:07:49+05:00
Go to Top